Filed: 2/13/2026ACC: 0000919574-26-000956
📋 What this filing means
CAXTON CORP filed this quarterly 13F‑HR report disclosing 11 equity positions with a total reported market value of $4.28M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
11
Positions
$4.28M
Total AUM (reported)
167.43K
Total Shares
Allocation by class
GOLD SHS$2.76M64.5%
COM NEW$662.2K15.5%
COM$500.4K11.7%
CL B NEW$356.8K8.3%
Portfolio Concentration
Top 3$3.41M79.7%
4–10$843.3K19.7%
11–25$27.1K0.6%
Top 3 weight
79.7%
Top 10 weight
99.4%
Voting Authority Distribution
Total shares with voting rights: 167.43K
Sole
Full voting authority
167.43K
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole11
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings11
Rows:
SPDR GOLD TR
SOLEShares6.96K
TypeSH
Market value$2.76M
64.50%
Sole
6.96K
Shared
0.00
None
0.00
BERKSHIRE HATHAWAY INC DEL
SOLEShares710.00
TypeSH
Market value$356.8K
8.34%
Sole
710.00
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares8.92K
TypeSH
Market value$292.2K
6.83%
Sole
8.92K
Shared
0.00
None
0.00
MIND MEDICINE MINDMED INC
SOLEShares15.69K
TypeSH
Market value$210.1K
4.91%
Sole
15.69K
Shared
0.00
None
0.00
KYVERNA THERAPEUTICS INC
SOLEShares18.77K
TypeSH
Market value$176.5K
4.12%
Sole
18.77K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares29.50K
TypeSH
Market value$158.4K
3.70%
Sole
29.50K
Shared
0.00
None
0.00
LEXEO THERAPEUTICS INC
SOLEShares13.94K
TypeSH
Market value$138.5K
3.24%
Sole
13.94K
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares15.56K
TypeSH
Market value$62.2K
1.45%
Sole
15.56K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares28.45K
TypeSH
Market value$58.3K
1.36%
Sole
28.45K
Shared
0.00
None
0.00
SAB BIOTHERAPEUTICS INC
SOLEShares10.53K
TypeSH
Market value$39.4K
0.92%
Sole
10.53K
Shared
0.00
None
0.00
CONTEXT THERAPEUTICS INC
SOLEShares18.40K
TypeSH
Market value$27.1K
0.63%
Sole
18.40K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR GOLD TRSOLE | GOLD SHS | 6.96K | SH | $2.76M 64.50% | 6.96K | 0.00 | 0.00 |
BERKSHIRE HATHAWAY INC DELSOLE | CL B NEW | 710.00 | SH | $356.8K 8.34% | 710.00 | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 8.92K | SH | $292.2K 6.83% | 8.92K | 0.00 | 0.00 |
MIND MEDICINE MINDMED INCSOLE | COM NEW | 15.69K | SH | $210.1K 4.91% | 15.69K | 0.00 | 0.00 |
KYVERNA THERAPEUTICS INCSOLE | COM | 18.77K | SH | $176.5K 4.12% | 18.77K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 29.50K | SH | $158.4K 3.70% | 29.50K | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 13.94K | SH | $138.5K 3.24% | 13.94K | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM NEW | 15.56K | SH | $62.2K 1.45% | 15.56K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 28.45K | SH | $58.3K 1.36% | 28.45K | 0.00 | 0.00 |
SAB BIOTHERAPEUTICS INCSOLE | COM NEW | 10.53K | SH | $39.4K 0.92% | 10.53K | 0.00 | 0.00 |
CONTEXT THERAPEUTICS INCSOLE | COM | 18.40K | SH | $27.1K 0.63% | 18.40K | 0.00 | 0.00 |